0.00Open0.54Pre Close0 Volume5 Open Interest71.00Strike Price0.00Turnover444.80%IV12.00%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.54Extrinsic Value100Contract SizeAmericanOptions Type-0.1198Delta0.0229Gamma148.28Leverage Ratio-3.9580Theta-0.0001Rho-17.77Eff Leverage0.0039Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet